Read more

February 05, 2021
1 min read
Save

Top in GI: Sweat sensor for IBD, diagnostic tool for small intestinal bacterial overgrowth

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Researchers developed a wearable sweat sensor that can predict flareups of inflammatory bowel disease. A summary of their findings on the performance of the device was the top story in gastroenterology last week.

Another top story was about a capsule diagnostic system for small intestinal bacterial overgrowth and its potential to become the gold standard for diagnosis.

Woman with stomach pain
Source: Adobe Stock

Read these and more top stories in gastroenterology below:

Wearable sweat sensing device may lead to better treatment of IBD

Researchers developed a wearable sweat senser device that may improve the treatment of inflammatory bowel disease (IBD), according to a presenter at the virtual Crohn’s and Colitis Congress. Read more.

VIDEO: Capsule diagnostic may become gold standard for SIBO

In this exclusive video, Satish Rao, MD, PhD, from Augusta University, discusses the current landscape of small intestinal bacterial overgrowth diagnosis and the future impact of a capsule diagnostic system. Read more.

Specific carbohydrate diets, even modified, improve pediatric IBD symptoms

Data showed that pediatric patients adhering to a specific carbohydrate diet or modified specific carbohydrate diet showed improved symptoms of their IBD. Read more.

Patients with IBD should receive COVID-19 vaccine, despite concerns

Physicians should encourage patients with IBD to be vaccinated against COVID-19 despite the lack of studies evaluating its safety and efficacy in this population, according to a presentation at the Crohn’s and Colitis Congress. Read more.

NAFLD linked with increased readmissions in IBD

Patients with IBD who also had non-alcoholic fatty liver disease had higher readmission rates, a recent study showed. Read more.